5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.40%
Revenue growth under 50% of STERV.HE's 3.56%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.13%
Negative gross profit growth while STERV.HE is at 25.85%. Joel Greenblatt would examine cost competitiveness or demand decline.
3.20%
EBIT growth below 50% of STERV.HE's 99.31%. Michael Burry would suspect deeper competitive or cost structure issues.
3.20%
Operating income growth under 50% of STERV.HE's 99.31%. Michael Burry would be concerned about deeper cost or sales issues.
4.89%
Net income growth under 50% of STERV.HE's 171.59%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.69%
EPS growth under 50% of STERV.HE's 172.73%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.69%
Diluted EPS growth under 50% of STERV.HE's 172.73%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.60%
Share reduction while STERV.HE is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.60%
Reduced diluted shares while STERV.HE is at 0.18%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
8.87%
Positive OCF growth while STERV.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
30.49%
Positive FCF growth while STERV.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-34.34%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-2.62%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
6.36%
Positive 3Y CAGR while STERV.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
515.31%
10Y OCF/share CAGR above 1.5x STERV.HE's 86.71%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
16.93%
5Y OCF/share CAGR above 1.5x STERV.HE's 8.52%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-22.54%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
306.82%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
76.98%
Positive 5Y CAGR while STERV.HE is negative. John Neff might view this as a strong mid-term relative advantage.
18.81%
3Y net income/share CAGR 50-75% of STERV.HE's 37.36%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
28.48%
10Y equity/share CAGR at 50-75% of STERV.HE's 42.00%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
27.95%
Below 50% of STERV.HE's 63.47%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
20.26%
Below 50% of STERV.HE's 46.60%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.55%
Firm’s AR is declining while STERV.HE shows 2.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-2.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
3.16%
Asset growth well under 50% of STERV.HE's 15.80%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
8.29%
Under 50% of STERV.HE's 21.61%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-2.13%
We’re deleveraging while STERV.HE stands at 5.91%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
15.04%
SG&A growth well above STERV.HE's 3.68%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.